To investigate the relative importance of individual tissue Doppler imaging variables to predict adverse events in a high-risk population with diabetes, ischaemic heart disease, and/or systolic dysfunction.
Introduction
In order to improve outcomes in cardiovascular high-risk populations like those with diabetes, ischaemic heart disease, and systolic dysfunction, it is of importance to identify characteristics that is predictive for adverse events. Echocardiography plays an important role in this context and left ventricular ejection fraction (LVEF) is currently the most frequently used parameter for risk stratification in these patients. 1, 2 Nevertheless, LVEF is only a rough measurement of systolic function and tissue Doppler imaging (TDI) may be a sensitive supplement to conventional echocardiography. Because it is easily obtained and widely available, TDI is increasingly used in clinical practice, but the relative importance of impairments of different variables remains to be firmly established. Previous studies of patients with left ventricular systolic dysfunction reported that both systolic-and late diastolic longitudinal tissue velocities were associated with mortality after adjustment for LVEF. 3, 4 Using the general population, in whom most subjects were without cardiac disease, Mogelvang et al. 5 recently reported similar findings, but also reported an important inter-relationship between the two variables. We studied the prognostic importance of peak systolic (s ′ ), early diastolic (e ′ ), and late diastolic (a ′ ) longitudinal tissue velocities in a heterogeneous high-risk population of diabetic patients with particular emphasis on the inter-relationship between individual tissue Doppler variables.
Methods Data sources
At Department of Cardiology, Gentofte University Hospital, a tertiary invasive centre located in the region of Copenhagen, routine echocardiograms were performed according to a standardized protocol and have been stored at a local hard disk since mid-2005. Further, all coronary angiographies performed at the hospital have been registered in a local database since 1999. Information available in the database includes coronary pathology (graded by visual analysis), co-morbidity, dates of investigation, and the presence of cardiac pacemaker. The database also includes information on heart failure status, as based on clinician's estimation. By the use of the nationwide administrative registers of prescription claims, hospitalizations, and deaths available in Denmark, we were able to obtain the complete status on pharmacotherapy, heart failure hospitalizations, and mortality on follow-up of the study cohort.
Study population
For the present study, we identified all patients with diabetes who had a coronary angiography performed in the period between mid-2005 and end of 2008. We then evaluated all echocardiograms performed in temporal connection with the coronary angiography and included those who had measurements of TDI available and who were without atrial fibrillation, pacemaker, bundle branch block, congenital heart disease, and significant valve disease.
Echocardiography analyses
All echocardiograms were obtained using GE Vivid 7 ultrasound system. For the present study, all echocardiograms were analysed de novo by one single investigator, who was blinded to follow-up data, using the Echopac '08 software (GE Medical Systems, Horton, Norway). Intra-and interobserver variability have been presented previously. 6 Left ventricular longitudinal peak velocities were obtained from two-dimensional colour-coded TDI loops. The peak systolic (s ′ ), early diastolic (e ′ ), and late diastolic (a ′ ) tissue velocities were measured in the basal segments just proximal to the mitral annulus. A sample width and height of 7 × 15 mm was used. Presented values were mean values from both sides of three apical views (i.e. fourchamber, two-chamber, and apical long-axis views).
Left ventricular end-diastolic dimensions (interventricular septum wall thickness, end-diastolic inner diameter, and posterior wall thickness) were obtained from the parasternal long-axis view. Biplane LVEF and left atrial volumes were obtained using Simpson's method. Diastolic function was assessed using transmitral flow velocity profiles (obtained by pulsed-wave Doppler) and TDI velocities from the lateral and medial mitral annulus. 7 
Identification of pharmacotherapy
The 'Danish Register of Medicinal Product Statistics' held information on all dispensed prescriptions from Danish pharmacies since 1995. All drugs were registered at an individual level according to the Anatomical Therapeutic Chemical (ATC) classification system. The use of a specific agent was defined as at least one claimed prescription during a period of 3 months before to 30 days after echocardiography investigation. This method has been described in detail previously. 8 
Definition of outcomes
Using the 'Danish National Patient Register', data on all hospitalizations in Denmark until the end of 2008 were identified. All hospitalizations in the register were registered according to the International Classification of Diseases 10th revision (ICD-10) with one primary (A) and any secondary (B) diagnoses. We identified all patients who were hospitalized because of heart failure (i.e. primary diagnoses only) using the following ICD-10 codes: I50, I42, I110, and J819. Using the National Death register, we were also able to identify all patients who died before the end of 2008.
Statistics
Uni-and multivariable Cox's proportional hazard regression models were used to assess the risk of heart failure hospitalization and death as dependent on different variables (measurements of s ′ were included after multiplying TDI velocities by 21). The final Cox's model was adjusted for age, gender, coronary artery pathology, clinical heart failure at baseline, LVEF, and s ′ , e ′ , and a ′ (all variables were decided a priori and all patients had complete measurements of included variables). Finally, because some of the patients received a coronary artery bypass graft (CABG) operation after coronary angiography and because CABG is known to increase the risk of heart failure and death, we performed a time-dependent Cox analysis, where CABG status was continuously updated (every day), as sensitivity analysis. Tests for interactions between the different TDI variables were performed by inclusion of an interaction term in overall analysis. Design variables were then created to explore the importance of significant interactions (i.e. all patients were analysed in one model). Test for differences between groups were performed by the x 2 test and Kruskal -Wallis test for discrete and continuous groups, respectively. All analyses were performed using SAS version 9.2 (Cary, NC, USA).
Ethics
The study was approved by the Danish Data Protection Agency (No. 2007-41-1667). Retrospective register-based studies do not need ethical approval in Denmark.
Results
Between mid-2005 and December 2008, 10 964 patients underwent coronary angiography. A total of 1670 patients had diabetes and 720 of these patients had been subjected to echocardiography at some point in time during the investigational period. In total, 388 fulfilled the selection criteria and formed the present study population. Echocardiography investigation of the included patients was performed in median 1 day after coronary angiography investigation (inter-quartile range 0-2 days). Baseline characteristics of the study population, overall and stratified by clinical heart failure, are shown in Table 1 . The overall mean age was 66 (+standard deviation 10) years and 78% were men. The mean LVEF was 45(+12)% and 34% had an Importance and inter-relationship of TDI variables LVEF ≥50%. The majority (75%) of the patients was confirmed with coronary artery disease and 32% were referred with acute myocardial infarction. Totally, 27% of the study population had clinical heart failure at baseline.
Survival analyses
Patients were followed in mean 2.3 (+standard deviation 1.0) years. During this period, 50 patients (13%) were hospitalized because of heart failure and 52 patients (14%) died. Ninety-one patients (23%) met the combined endpoint over a total of 843 person-years, giving an overall incidence rate of 110 cases per 1000 person-years. Being referred with acute myocardial infarction was without prognostic importance, adjusted hazard ratio (HR) 0.90 (0.56-1.46). Adjusted HRs were 0.81 (0.33-1.98), 1.55 (0.71-3.38), and 1.66 (0.91-3.02) for one-, two-, and three-vessel disease, compared with no coronary artery disease. Unadjusted and adjusted HRs associated with different variables from the Cox models are shown in Table 2 . For the combined endpoint and the heart failure hospitalization endpoint, in particular a Because of a previously reported association between the E/e ′ ratio and risk of heart failure hospitalizations in patients with diabetes, 9 we also challenged the ability of the E/e ′ ratio (as a dichotomous variable, defined as E/e ′ ratio ≥15) to predict events in our study population. As an unadjusted variable, an elevated E/e ′ ratio was associated with both the risk of heart failure hospitalizations and deaths ( Table 2) , whereas it was without prognostic importance in multivariable analyses (P ¼ 0.5 for the combined endpoint, P ¼ 0.5 for the heart failure endpoint, and P ¼ 0.2 for the mortality endpoint after adjusting for age, gender, coronary artery pathology, clinical heart failure at baseline, and LVEF).
Inter-relationship between s ′ , a ′ , and e ′ and relation to other variables
The three TDI variables s ′ , e ′ , and a ′ were, to a different extent, found be associated with each other and with LVEF, left ventricular end-diastolic diameter, and E/e ′ ratio, as presented in respectively. Separate analyses of the mortality endpoint and the heart failure hospitalization endpoint found similar but statistically insignificant results, P-value for interactions ¼ 0.07 and 0.09, respectively. There was no interaction between s ′ and e ′ (P ¼ 0.9 in analysis of the combined endpoint) or between e ′ and a ′ (P ¼
in analysis of the combined endpoint).
Exploring the baseline characteristics of patients within the low s ′ and low a ′ groups, these were found to be older and have a lower LVEF, compared with the other patients (69 + 10 vs. 64 + 9 years, and 39 + 13 vs. 47 + 11%; P , 0.0001). They were also found to have a higher E/e ′ ratio (14 + 7 vs. 10 + 4, P , 0.0001), higher use of loop diuretics (53 vs. 27%, P , 0.0001), spironolactone (21 vs. 7%, P , 0.0001), and more often clinical heart failure at baseline (44 vs. 19%, P , 0.0001). The burden of vessel disease at coronary angiography and the proportion of patients referred with acute myocardial infarction at the time of coronary investigation were not different from the other groups.
Sensitivity analyses
In total, 25% of the study population received a CABG operation during follow-up (median time being 30 days after echocardiography). The time-dependent Cox's analysis, where status on CABG was included as a time-dependent variable, gave similar results as the main analyses. For the combined endpoint, 1 cm/s decrease in s ′ , e ′ , and a ′ was associated with adjusted HRs (95% CI) of 1.20 (0.90-1.60), 1.02 (0.86-1.22), and 1.20 (1.05-1.37), respectively.
Discussion
In the present study, we investigated whether prediction of heart failure hospitalizations and deaths could be improved by the use of TDI in a heterogeneous and high-risk cohort of diabetic patients undergoing coronary angiography. During the rather short followup time of in mean 2.3 years, we found that particularly the risk of being hospitalized with heart failure could be well predicted by TDI. Indeed, TDI was shown to be more closely correlated with the prognosis that was the actual vessel disease (which is in agreements with previous findings of left ventricular function being more predictive for outcomes in post-myocardial infarction patients than the burden of coronary artery disease).
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Of the three studied variables (s ′ , e ′ , and a ′ ), both s ′ and a ′ added information on the prognosis. At least one previous study of patients with systolic dysfunction found s ′ to be the most strong predictor of mortality, 3 whereas another study found a ′ to be strongly associated with the risk of mortality or heart failure. 4 In our cohort of diabetes patients, of whom most had impairments in systolic function, we found that both s ′ and a ′ were significantly associated with the combined endpoint of risk of heart failure hospitalization and mortality, but not with mortality alone, which may be due to the rather short follow-up. Important, we did find that s ′ and a ′ interacted on prognosis, indicating that the two variables need to be considered together. This corresponds well with the finding reported by Mogelvang et al. 5 In this latter study, a similar inter-relationship between s ′ and a ′ was found for individuals without apparent cardiac disease, leading to the development of the eas-index [e ′ /(a ′ × s ′ )]. In our study population, the eas-index was less precise than were (s ′ , e ′ , and a ′ ) as separate variables, which again may be explained by the short time of follow-up and the high-risk population studied. Thus, the most important finding of our study was that a ′ was an important prognostic marker when s ′ was low. In patients having a low s ′ , having high a ′ was found to be protective, whereas a low a ′ in these patients was associated with substantially worsened prognosis. Similar, in patients with low a ′ , only those with concomitant impairments in s ′ had a poor prognosis. Considering that LVEF was lowest in the group with low s ′ and low a ′ and that inter-and intra-observer variation are rather high for estimation of LVEF, compared with estimation longitudinal TDI variables, it is possible that some of the incremental prognostic value of TDI lay within higher accuracy of assessment of left ventricle function. Decreasing a ′ has previously been shown to correlate with decreasing left atrial dP/dt as well as increasing left ventricular enddiastolic pressure, which are both measurements of preload.
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Although not very close, a ′ was found to be correlated with both the E/e ′ ratio and left atrial size in our study population, suggesting that a ′ may primarily be a measure of left ventricular filling pressure. In this context, a ′ was also shown to be rather closely correlated with s ′ in the study population (they shared 35% of the variability), which may relate to previous findings of higher left ventricular filling pressures correlating with larger infarcts and more severe systolic dysfunction among patients with myocardial infarction. 12 Because the majority of patients in the present study population had significant impairments in systolic function and a depressed LVEF, it is mechanistically plausible that a ′ tended to add more prognostic information than s ′ in most analyses. Nevertheless, in a clinical context, it seems reasonable to start with evaluating s ′ and if impaired then consider the value of a ′ . Cut-off points for an impaired vs. not impaired s ′ and a ′ remain to be established. Several previous studies of myocardial infarction and heart failure populations have demonstrated that an elevated E/e ′ ratio is predictive of adverse outcomes. 13 The E/e ′ ratio measured during exercise (as a proxy of functional reserve) was also recently found to be predictive of clinical adverse outcomes in patients with type 2 diabetes without overt cardiac disease. 14 As a univariable predictor (i.e. E/e ′ ratio at rest), we did confirm such a relationship, but when adjusting for other factors, an elevated E/e ′ ratio was not found to be significantly associated with outcomes any longer, suggesting that it may be a rather insensitive measurement in cohorts with high prevalence of systolic dysfunction, such as the present one.
Conclusion and clinical implications
Prediction of heart failure hospitalizations and mortality in a heterogeneous and high-risk cohort of diabetes patients and suspected ischaemic heart disease could be substantially improved by addition of TDI to conventional echocardiography. We suggest that s ′ should be considered as a supplement to conventional echocardiography in all patients and if impaired, then the value of a ′ should be considered, because a low a ′ in these patients is independently associated with increased risk of adverse events. More studies on the subject are warranted to confirm this relationship.
Limitations
The main limitation of the present study relates to its observational design, the rather low number of subjects meeting the study endpoints, the short follow-up period, and the lack of values on blood pressures and data on blood biochemistry, such as HbA1c and brain natriuretic peptide. The present study also lacked measurements of global longitudinal strain and strain rates (longitudinal as well as circumferential), which also may be useful predictors of adverse outcomes in myocardial infarction and heart failure patients. 15, 16 The study centre functioned as a tertiary invasive centre, and therefore, the study population may not reflect a general population of patients with diabetes and ischaemic heart disease. The sensitivity of heart failure diagnosis (as a primary diagnosis) also needs to be mentioned as a limitation, because it is mainly unknown. Therefore, being retrospective and with the above-mentioned limitations, data should be considered as hypothesis-generating only.
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